Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4630-4645

  Alam, Samina ^a   Bowser, Brian S ^a   Conway, Michael J ^a   Israr, Mohd ^a   Ryndock, Eric J ^a   Xi, Long Fu ^b   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; P21WAF1 PROTEIN; PROTEIN P53; PURVALANOL A; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL INTERACTION; CELL PROLIFERATION; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HOST CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 31; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNTHESIS; UPREGULATION; VIRION; VIRUS INFECTION; VIRUS PARTICLE;

BENZO(A)PYRENE; CARCINOGENS; CELL LINE; CYCLIN B; ENZYME INHIBITORS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 31;

EID: 77950796583     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02431-09     Document Type: Article

References (85)

1. Abelev, G. I. 2000. Differentiation mechanisms and malignancy. Biochemistry (Mosc.) 65:107-116.
2. Alam, S., M. J. Conway, H. S. Chen, and C. Meyers. 2008. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J. Virol. 82:1053-1058.
3. Alam, S., E. Sen, H. Brashear, and C. Meyers. 2006. Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line. J. Virol. 80:4927-4939.
4. Andrysik, Z., J. Vondracek, M. Machala, P. Krcmar, L. Svihalkova-Sindlerova, A. Kranz, C. Weiss, D. Faust, A. Kozubik, and C. Dietrich. 2007. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells. Mutat. Res. 615:87-97.
5. Asselineau, D., and M. Prunieras. 1984. Reconstruction of 'simplified' skin: control of fabrication. Br. J. Dermatol. 111(Suppl. 27):219-222.
6. Baird, W. M., L. A. Hooven, and B. Mahadevan. 2005. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45:106-114.
7. Barrasa, M. I., J. T. Guo, J. Saputelli, W. S. Mason, and C. Seeger. 2001. Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids? J. Virol. 75:2024-2028.
8. Burdick, A. D., J. W. Davis II, K. J. Liu, L. G. Hudson, H. Shi, M. L. Monske, and S. W. Burchiel. 2003. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res. 63:7825-7833.
9. Caino, M. C., J. L. Oliva, H. Jiang, T. M. Penning, and M. G. Kazanietz. 2007. Benzo[a]pyrene-7,8-dihydrodiol promotes checkpoint activation and G2/M arrest in human bronchoalveolar carcinoma H358 cells. Mol. Pharmacol. 71:744-750.
10. Castellsague, X., F. X. Bosch, and N. Munoz. 2002. Environmental co-factors in HPV carcinogenesis. Virus Res. 89:191-199.
11. Castle, P. E., S. Wacholder, M. E. Sherman, A. T. Lorincz, A. G. Glass, D. R. Scott, B. B. Rush, F. Demuth, and M. Schiffman. 2002. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 95:2145-2151.
12. Clark, W., E. J. Black, A. MacLaren, U. Kruse, N. LaThangue, P. K. Vogt, and D. A. Gillespie. 2000. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Mol. Cell. Biol. 20:2529-2542.
13. Coffman, F. D., and G. P. Studzinski. 1999. Differentiation-related mechanisms which suppress DNA replication. Exp. Cell Res. 248:58-73.
14. Conte, D., Jr., E. Barber, M. Banerjee, D. J. Garfinkel, and M. J. Curcio. 1998. Posttranslational regulation of Ty1 retrotransposition by mitogen-activated protein kinase Fus3. Mol. Cell. Biol. 18:2502-2513.
15. Conway, M. J., S. Alam, N. D. Christensen, and C. Meyers. 2009. Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology 393:295-303.
16. Conway, M. J., S. Alam, E. J. Ryndock, L. Cruz, N. D. Christensen, R. B. Roden, and C. Meyers. 2009. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J. Virol. 83:10515-10526.
17. Davy, C., and J. Doorbar. 2007. G2/M cell cycle arrest in the life cycle of viruses. Virology 368:219-226. (Pubitemid 350016216)
18. Davy, C. E., D. J. Jackson, K. Raj, W. L. Peh, S. A. Southern, P. Das, R. Sorathia, P. Laskey, K. Middleton, T. Nakahara, Q. Wang, P. J. Masterson, P. F. Lambert, S. Cuthill, J. B. Millar, and J. Doorbar. 2005. Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J. Virol. 79:3998-4011.
19. De Buck, S. S., P. Augustijns, and C. P. Muller. 2005. Specific antibody modulates absorptive transport and metabolic activation of benzo[a]pyrene across Caco-2 monolayers. J. Pharmacol. Exp. Ther. 313:640-646.
20. Dipple, A., Q. A. Khan, J. E. Page, I. Ponten, and J. Szeliga. 1999. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens. Int. J. Oncol. 14:103-111.
21. 2/M cell cycle arrest, p21CIP1 and p53 phosphorylation in human choriocarcinoma JEG-3 cells: a distinct signaling pathway. Placenta 26(Suppl. A):S87-S95.
22. Fuchs, E. 1990. Epidermal differentiation: the bare essentials. J. Cell Biol. 111:2807-2814.
23. Funk, J. O., and D. A. Galloway. 1998. Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem. Sci. 23:337-341.
24. Funk, J. O., S. Waga, J. B. Harry, E. Espling, B. Stillman, and D. A. Galloway. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090-2100.
25. Garrett, L. R., N. Perez-Reyes, P. P. Smith, and J. K. McDougall. 1993. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 14:329-332. (Pubitemid 23143418)
26. Gartel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138-149.
27. Harris, T. G., S. L. Kulasingam, N. B. Kiviat, C. Mao, S. N. Agoff, Q. Feng, and L. A. Koutsky. 2004. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am. J. Epidemiol. 159:834-842.
28. Hecht, S. S. 2003. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3:733-744.
29. Herrington, C. S. 1995. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J. Clin. Pathol. 48:1-6.
30. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
31. Hocke, C., V. Leroy, P. Morlat, J. Rivel, M. C. Duluc, N. Boulogne, B. Tandonnet, M. Dupon, J. L. Brun, and F. Dabis. 1998. Cervical dysplasia and human immunodeficiency virus infection in women: prevalence and associated factors. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GESCA). Eur. J. Obstet. Gynecol. Reprod. Biol. 81:69-76.
32. International Agency for Research on Cancer. 2004. IARC monographs on the evaluation of carcinogenic risks to humans, vol.83. Tobacco smoke and involuntary smoking. International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
33. Israr, M., D. Mitchell, S. Alam, D. Dinello, J. J. Kishel, and C. Meyers. Effect of HIV protease inhibitor Amprenavir on the growth and differentiation of primary gingival epithelium. Antivir. Ther., in press.
34. Jyonouchi, H., S. Sun, K. Iijima, M. Wang, and S. S. Hecht. 1999. Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol. Carcinogenesis 20:139-145.
35. Khan, Q. A., and A. Dipple. 2000. Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells. Carcinogenesis 21:1611-1618.
36. Khan, Q. A., A. Dipple, and L. M. Anderson. 2002. Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells. Mol. Carcinog. 33:1-8.
37. Khleif, S. N., J. DeGregori, C. L. Yee, G. A. Otterson, F. J. Kaye, J. R. Nevins, and P. M. Howley. 1996. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. U. S. A. 93:4350-4354.
38. Kim, S. J., S. Nakayama, Y. Miyoshi, T. Taguchi, Y. Tamaki, T. Matsushima, Y. Torikoshi, S. Tanaka, T. Yoshida, H. Ishihara, and S. Noguchi. 2008. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann. Oncol. 19:68-72.
39. Klaes, R., T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U. Petry, G. Dallenbach-Hellweg, D. Schmidt, and M. von Knebel Doeberitz. 2001. Over-expression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92:276-284. (Pubitemid 32225381)
40. Ko, C. B., S. J. Kim, C. Park, B. R. Kim, C. H. Shin, S. Choi, S. Y. Chung, J. H. Noh, J. H. Jeun, N. S. Kim, and R. Park. 2004. Benzo(a)pyrene- induced apoptotic death of mouse hepatoma Hepa1c1c7 cells via activation of intrinsic caspase cascade and mitochondrial dysfunction. Toxicology 199:35-46.
41. Leisenfelder, S. A., P. R. Kinchington, and J. F. Moffat. 2008. Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions. J. Virol. 82:12116-12125.
42. Li, J., H. Chen, Q. Ke, Z. Feng, M. S. Tang, B. Liu, S. Amin, M. Costa, and C. Huang. 2004. Differential effects of polycyclic aromatic hydrocarbons on transactivation of AP-1 and NF-kappaB in mouse epidermal cl41 cells. Mol. Carcinog. 40:104-115.
43. Li, S. L., M. S. Kim, H. M. Cherrick, J. Doniger, and N. H. Park. 1992. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis 13:1981-1987.
44. MacCorkle, R. A., and T. H. Tan. 2005. Mitogen-activated protein kinases in cell-cycle control. Cell Biochem. Biophys. 43:451-461.
45. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
46. Martinez, A., M. Portero-Otin, R. Pamplona, and I. Ferrer. 6 August 2009. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol. doi:10.1111/j.1750-3639.2009.00326.x. [Epub ahead of print.]
47. Melikian, A. A., P. Sun, B. Prokopczyk, K. El-Bayoumy, D. Hoffmann, X. Wang, and S. Waggoner. 1999. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett. 146:127-134.
48. Melikian, A. A., X. Wang, S. Waggoner, D. Hoffmann, and K. El-Bayoumy. 1999. Comparative response of normal and of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene. Oncol. Rep. 6:1371-1376.
49. Meyers, C. 2002. Epithelial cell culture: three-dimensional cervical system, p. 263-271. In A. Atala and R. P. Lanza (ed.), Methods of tissue engineering. Academic Press, San Diego, CA.
50. Meyers, C. 1996. Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Methods Cell Sci. 18:1-10.
51. Meyers, C., S. Alam, M. Mane, and P. L. Hermonat. 2001. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology 287:30-39. (Pubitemid 32778236)
52. Meyers, C., J. L. Bromberg-White, J. Zhang, M. E. Kaupas, J. T. Bryan, R. S. Lowe, and K. U. Jansen. 2002. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J. Virol. 76:4723-4733. (Pubitemid 34441678)
53. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
54. Moscicki, A. B., N. Hills, S. Shiboski, K. Powell, N. Jay, E. Hanson, S. Miller, L. Clayton, S. Farhat, J. Broering, T. Darragh, and J. Palefsky. 2001. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285:2995-3002.
55. Nischan, P., K. Ebeling, and C. Schindler. 1988. Smoking and invasive cervical cancer risk. Results from a case-control study. Am. J. Epidemiol. 128:74-77.
56. Noya, F., W. M. Chien, T. R. Broker, and L. T. Chow. 2001. p21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7. J. Virol. 75:6121-6134. (Pubitemid 32553143)
57. Ozbun, M. A., and C. Meyers. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
58. Ozbun, M. A., and C. Meyers. 1996. Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J. Virol. 70:5437-5446. (Pubitemid 26240718)
59. Park, N. H., C. N. Gujuluva, J. H. Baek, H. M. Cherrick, K. H. Shin, and B. M. Min. 1995. Combined oral carcinogenicity of HPV-16 and benzo-(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10:2145-2153.
60. Perez, D. S., L. Armstrong-Lea, M. H. Fox, R. S. Yang, and J. A. Campain. 2003. Arsenic and benzo[a]pyrene differentially alter the capacity for differentiation and growth properties of primary human epidermal keratinocytes. Toxicol. Sci. 76:280-290.
61. Pitot, H. C., and Y. P. Dragon. 1996. Chemical carcinogenesis, p. 201-267. In C. D. Klaassen (ed.), Casarett & Doull's toxicology: the basic science of poisons, 5th ed. McGraw-Hill, New York, NY.
62. Pliskova, M., J. Vondracek, B. Vojtesek, A. Kozubik, and M. Machala. 2005. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol. Sci. 83:246-256.
63. Prokopczyk, B., J. E. Cox, D. Hoffmann, and S. E. Waggoner. 1997. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 89:868-873.
64. Reed, M., M. Monske, F. Lauer, S. Meserole, J. Born, and S. Burchiel. 2003. Benzo[a]pyrene diones are produced by photochemical and enzymatic oxidation and induce concentration-dependent decreases in the proliferative state of human pulmonary epithelial cells. J. Toxicol. Environ. Health A 66:1189-1205.
65. Rorke, E. A., N. Sizemore, H. Mukhtar, L. H. Couch, and P. C. Howard. 1998. Polycyclic aromatic hydrocarbons enhance terminal cell death of human ectocervical cells. Int. J. Oncol. 13:557-563.
66. Rubin, H. 2001. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 22:1903-1930. (Pubitemid 34065385)
67. Ruesch, M., F. Stubenrauch, and L. Laimins. 1998. Activation of papillo-mavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin 10. J. Virol. 72:5016-5024. (Pubitemid 28219292)
68. Rummel, A. M., J. E. Trosko, M. R. Wilson, and B. L. Upham. 1999. Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity. Toxicol. Sci. 49:232-240.
69. Sadhu, D. N., M. Merchant, S. H. Safe, and K. S. Ramos. 1993. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo- [a]pyrene. Arch. Biochem. Biophys. 300:124-131.
70. Sanchez, I., and B. D. Dynlacht. 2005. New insights into cyclins, CDKs, and cell cycle control. Semin. Cell Dev. Biol. 16:311-321.
71. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707. (Pubitemid 24036021)
72. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
73. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
74. Sizemore, N., H. Mukhtar, L. H. Couch, P. C. Howard, and E. A. Rorke. 1995. Differential response of normal and HPV immortalized ectocervical epithelial cells to B[a]P. Carcinogenesis 16:2413-2418.
75. Solhaug, A., M. Refsnes, M. Lag, P. E. Schwarze, T. Husoy, and J. A. Holme. 2004. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 25:809-819. (Pubitemid 38618535)
76. Sotlar, K., A. Stubner, D. Diemer, S. Menton, M. Menton, K. Dietz, D. Wallwiener, R. Kandolf, and B. Bultmann. 2004. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J. Med. Virol. 74:107-116.
77. Tannheimer, S. L., S. L. Barton, S. P. Ethier, and S. W. Burchiel. 1997. Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis 18:1177-1182.
78. Tsai, K. S., R. S. Yang, and S. H. Liu. 2004. Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway. Chem. Res. Toxicol. 17:679-684.
79. Vineis, P., M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, F. Sitas, J. Smith, L. Stayner, K. Straif, M. J. Thun, H. E. Wichmann, A. H. Wu, D. Zaridze, R. Peto, and R. Doll. 2004. Tobacco and cancer: recent epidemiological evidence. J. Natl. Cancer Inst. 96:99-106.
80. Wells, P. G., G. P. McCallum, C. S. Chen, J. T. Henderson, C. J. Lee, J. Perstin, T. J. Preston, M. J. Wiley, and A. W. Wong. 2009. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol. Sci. 108:4-18.
81. Winkelstein, W., Jr. 1977. Smoking and cancer of the uterine cervix: hypothesis. Am. J. Epidemiol. 106:257-259.
82. Woodman, C. B., S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7:11-22.
83. Xi, L. F., L. A. Koutsky, P. E. Castle, Z. R. Edelstein, C. Meyers, J. Ho, and M. Schiffman. 2009. Relationship between cigarette smoking and human papillomavirus types 16 and 18 DNA load. Cancer Epidemiol. Biomarkers Prev. 18:3490-3496.
84. Xu, H., and J. D. Boeke. 1991. Inhibition of Ty1 transposition by mating pheromones in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:2736-2743.
85. Yao, B., J. Fu, E. Hu, Y. Qi, and Z. Zhou. 2007. The Cdc25A is involved in S-phase checkpoint induced by benzo(a)pyrene. Toxicology 237:210-217.